Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.

por Boven, E., Erkelens, C. A., Luning, M., Pinedo, H. M.
Publicado 1990

Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts

por Kolfschoten, G M, Hulscher, T M, Pinedo, H M, Boven, E
Publicado 2000

The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts.

por Boven, E., Hendriks, H. R., Erkelens, C. A., Pinedo, H. M.
Publicado 1992

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer.

por Boven, E., Schipper, H., Erkelens, C. A., Hatty, S. A., Pinedo, H. M.
Publicado 1993

Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.

por Kievit, E., Pinedo, H. M., Schlüper, H. M., Haisma, H. J., Boven, E.
Publicado 1996

Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.

por Molthoff, C. F., Pinedo, H. M., Schlüper, H. M., Nijman, H. W., Boven, E.
Publicado 1992

Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.

por Nauta, M. M., Boven, E., Schlüper, H. M., Erkelens, C. A., Pinedo, H. M.
Publicado 1986

CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.

por Jansen, W. J., Hulscher, T. M., van Ark-Otte, J., Giaccone, G., Pinedo, H. M., Boven, E.
Publicado 1998

A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer.

por Haisma, H. J., Boven, E., van Muijen, M., de Jong, J., van der Vijgh, W. J., Pinedo, H. M.
Publicado 1992

Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously.

por Honkoop, A. H., Hoekman, K., Wagstaff, J., van Groeningen, C. J., Vermorken, J. B., Boven, E., Pinedo, H. M.
Publicado 1996

Influence of single and multiple doses of amifostine on the efficacy and the pharmacokinetics of carboplatin in mice.

por Korst, A. E., Boven, E., van der Sterre, M. L., Fichtinger-Schepman, A. M., van der Vijgh, W. J.
Publicado 1997

Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats

por Verschraagen, M, Boven, E, Torun, E, Erkelens, C A M, Hausheer, F H, van der Vijgh, W J F
Publicado 2004

Reply: Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

por van der Veldt, A A M, Boven, E, van den Eertwegh, A J M, Haanen, J B A G
Publicado 2009

The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts.

por Houba, P. H., Boven, E., Erkelens, C. A., Leenders, R. G., Scheeren, J. W., Pinedo, H. M., Haisma, H. J.
Publicado 1998

Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule

por Boven, E, Westerman, M, van Groeningen, C J, Verschraagen, M, Ruijter, R, Zegers, I, van der Vijgh, W J F, Giaccone, G
Publicado 2005

Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

por van der Veldt, A A M, Meijerink, M R, van den Eertwegh, A J M, Haanen, J B A G, Boven, E
Publicado 2010

A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours

por Boven, E, Massard, C, Armand, J P, Tillier, C, Hartog, V, Brega, N M, Countouriotis, A M, Ruiz-Garcia, A, Soria, J C
Publicado 2010

CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells

por Fontijn, D, Duyndam, M C A, van Berkel, M P A, Yuana, Y, Shapiro, L H, Pinedo, H M, Broxterman, H J, Boven, E
Publicado 2006

Determinants of CPT-11 and SN-38 activities in human lung cancer cells.

por van Ark-Otte, J., Kedde, M. A., van der Vijgh, W. J., Dingemans, A. M., Jansen, W. J., Pinedo, H. M., Boven, E., Giaccone, G.
Publicado 1998

A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer

por Houba, P H J, Boven, E, Meulen-Muileman, I H van der, Leenders, R G G, Scheeren, J W, Pinedo, H M, Haisma, H J
Publicado 2001